89936 To amend the definition of the term “conference” and to allow applicants with a D.C. healthcare professional license to submit a copy of the license in lieu of an official transcript.
-
DEPARTMENT OF HEALTH
NOTICE OF PROPOSED RULEMAKING
The Director of the Department of Health (“Department”), pursuant to the authority set forth in section 302(14) of the District of Columbia Health Occupations Revision Act of 1985, effective March 25, 1986 (D.C. Law 6-99; D.C. Official Code § 3-1203.02 (14)) (2007 Repl.), Mayor’s Order 98-140, dated August 20, 1998, the SafeRx Amendment Act of 2008, effective March 26, 2008 (D.C. Law 17-0131; 55 DCR 4462), and Mayor’s Order 2008-94, dated July 3, 2008, hereby gives notice of his intent to take final rulemaking action to adopt the following amendments to Chapter 83 (Pharmaceutical Detailers) of Title 17 (Business, Occupations and Professions) of the District of Columbia Municipal Regulations (DCMR), in not less than thirty (30) days after the date of publication of this notice in the D.C. Register.
The purpose of this amendment is to amend the definition of the term “conference” to include a scientific or medical educational meeting or symposium accredited by a nationally recognized healthcare professional education accreditation body (e.g., the Accreditation Council for Continuing Medical Education, the Accreditation Council for Pharmacy Education, and the American Nurses Association) In addition, this amendment would allow an applicant for a pharmaceutical detailing license who is a healthcare professional holding an active license in good standing in the District to submit with his or her application a copy of his or her license in lieu of an official transcript.
An earlier version of these rules was published in the D.C. Register as a proposed rulemaking on June 26, 2009 at 56 DCR 5065. Written comments were received in connection with that notice from the Restaurant Association Metropolitan Washington and the Pharmaceutical Research and Manufacturers of America. The rulemaking was subsequently amended and is being published for an additional comment period. Additionally, § 8302 of Title 17, DCMR is being amended to allow healthcare professionals who hold an active license in good standing in the District to submit a copy of their license in lieu of an official transcript when applying for a pharmaceutical detailing license.
Chapter 83 (Pharmaceutical Detailers) of Title 17 (Business Occupations and Professions) of the DCMR is amended as follows:
Section 8302 is amended as follows:
8302 EDUCATIONAL REQUIREMENTS
8302.1 Except as otherwise provided in this chapter, an applicant shall furnish proof
satisfactory to the Board that the applicant is a graduate of an institution of higher
education recognized by the Board in accordance with § 742 of the Act, D. C.
Official Code § 3-1207.42 (2001).
8302.2 Except as provided in § 8302.3, an applicant shall submit an official certificate of graduation or a transcript in a sealed envelope from the institution of higher education to the Board with the completed application.
8302.3 An applicant who holds a health professional license for a profession
which requires a degree, may submit a copy of the license in lieu of an official
certificate of graduation or transcript as proof of having graduated from an
institution of higher education recognized by the Board in accordance with § 742
of the Act, D. C. Official Code § 3-1207.42.
8302.4 The Board may grant a license to practice pharmaceutical detailing to an applicant
who is a graduate of an institution of higher education from a foreign country, if
the institution or education program was accredited by an accrediting body recognized by the Secretary of the United States Department of Education or the Council on Postsecondary Accreditation at the time the applicant graduated.
8302.5 If a document required by this chapter is in a language other than English, an applicant shall arrange for its translation into English by a translation service acceptable to the Board and shall submit a translation signed by the translator attesting to its accuracy.
Section 8399.1 is amended as follows:
The following terms and their ascribed meanings are amended to read as follows:
Conference - (1) A meeting, symposium, exposition, exhibit, convention, assembly, or like gathering, including meetings of a regional, national, or international professional association, society, or body, for the discussion of health-related issues consisting of multi-pharmaceutical company or labeler representation and targeting a regional, national, or international audience; or (2) a scientific or medical educational meeting or symposium that is accredited by a nationally recognized healthcare professional education accreditation body (e.g., the Accreditation Council for Continuing Medical Education, the Accreditation Council for Pharmacy Education, and the American Nurses Association).
Applicant- A person applying for a license to practice pharmaceutical detailing under this chapter.
All persons desiring to comment on the subject matter of this proposed rulemaking action shall submit written comments, not later than thirty (30) days after the date of publication of this notice in the D.C. Register, to Kenneth Campbell, General Counsel, the Department of Health, Office of the General Counsel, 825 North Capitol Street, N.E., 4th Floor, Washington, D.C. 20002. Copies of the proposed rules may be obtained between the hours of 9:00 a.m. and 5:00 p.m. at the address listed above.
